These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Tobacco harm reduction: the need for new products that can compete with cigarettes. Fagerström KO, Bridgman K. Addict Behav; 2014 Mar; 39(3):507-11. PubMed ID: 24290207 [Abstract] [Full Text] [Related]
6. Emerging nicotine delivery products. Implications for public health. Benowitz NL. Ann Am Thorac Soc; 2014 Feb; 11(2):231-5. PubMed ID: 24575992 [Abstract] [Full Text] [Related]
7. Obsolete tobacco control themes can be hazardous to public health: the need for updating views on absolute product risks and harm reduction. Kozlowski LT, Abrams DB. BMC Public Health; 2016 May 24; 16():432. PubMed ID: 27221096 [Abstract] [Full Text] [Related]
8. Effect of smokeless tobacco product marketing and use on population harm from tobacco use policy perspective for tobacco-risk reduction. Kozlowski LT. Am J Prev Med; 2007 Dec 24; 33(6 Suppl):S379-86. PubMed ID: 18021913 [Abstract] [Full Text] [Related]
9. The place for harm reduction and product regulation in UK tobacco control policy. Gilmore AB, Britton J, Arnott D, Ashcroft R, Jarvis MJ. J Public Health (Oxf); 2009 Mar 24; 31(1):3-10. PubMed ID: 19109341 [Abstract] [Full Text] [Related]
10. Prospects for a nicotine-reduction strategy in the cigarette endgame: Alternative tobacco harm reduction scenarios. Kozlowski LT. Int J Drug Policy; 2015 Jun 24; 26(6):543-7. PubMed ID: 25795345 [Abstract] [Full Text] [Related]
11. Nicotine Reduction Strategy: State of the science and challenges to tobacco control policy and FDA tobacco product regulation. Benowitz NL, Henningfield JE. Prev Med; 2018 Dec 24; 117():5-7. PubMed ID: 29944901 [Abstract] [Full Text] [Related]
12. [Is "tobacco harm reduction" possible? Other countries' experiences and perspectives, and how they could inform tobacco control in Japan]. Katanoda K, Togawa K, Nakamura M. Nihon Koshu Eisei Zasshi; 2024 Mar 19; 71(3):141-152. PubMed ID: 38123330 [Abstract] [Full Text] [Related]
13. Tobacco, nicotine and harm reduction. Le Houezec J, McNeill A, Britton J. Drug Alcohol Rev; 2011 Mar 19; 30(2):119-23. PubMed ID: 21375611 [Abstract] [Full Text] [Related]
14. Permissive nicotine regulation as a complement to traditional tobacco control. Sumner W. BMC Public Health; 2005 Feb 24; 5():18. PubMed ID: 15730554 [Abstract] [Full Text] [Related]
15. Electronic cigarettes and alternative nicotine products. Hanson K. NCSL Legisbrief; 2014 Jul 24; 22(26):1-2. PubMed ID: 25514811 [Abstract] [Full Text] [Related]
16. Regulatory issues concerning the development and circulation of nicotine-containing products: a qualitative study. Rooke C, McNeill A, Arnott D. Nicotine Tob Res; 2013 Jun 24; 15(6):1052-9. PubMed ID: 23128517 [Abstract] [Full Text] [Related]
17. FDA's regulatory shift on tobacco control. Yang YT. Prev Med; 2018 Aug 24; 113():153-155. PubMed ID: 29866276 [Abstract] [Full Text] [Related]
18. Australian urban Indigenous smokers' perspectives on nicotine products and tobacco harm reduction. Yuke K, Ford P, Foley W, Mutch A, Fitzgerald L, Gartner C. Drug Alcohol Rev; 2018 Jan 24; 37(1):87-96. PubMed ID: 28493405 [Abstract] [Full Text] [Related]
19. Is there any legal and scientific basis for classifying electronic cigarettes as medications? Farsalinos KE, Stimson GV. Int J Drug Policy; 2014 May 24; 25(3):340-5. PubMed ID: 24709413 [Abstract] [Full Text] [Related]
20. Harm reduction in U.S. tobacco control: Constructions in textual news media. Eversman MH. Int J Drug Policy; 2015 Jun 24; 26(6):575-82. PubMed ID: 25727451 [Abstract] [Full Text] [Related] Page: [Next] [New Search]